Shandong Wit Dyne HealthLtd Future Growth
Future criteria checks 3/6
Shandong Wit Dyne HealthLtd is forecast to grow earnings and revenue by 16.5% and 14.5% per annum respectively. EPS is expected to grow by 16.6% per annum. Return on equity is forecast to be 20.7% in 3 years.
Key information
16.5%
Earnings growth rate
16.6%
EPS growth rate
Pharmaceuticals earnings growth | 19.3% |
Revenue growth rate | 14.5% |
Future return on equity | 20.7% |
Analyst coverage | Low |
Last updated | 29 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Is There An Opportunity With Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) 38% Undervaluation?
Oct 27There's No Escaping Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) Muted Earnings
Sep 14Shandong Wit Dyne HealthLtd (SZSE:000915) Is Increasing Its Dividend To CN¥2.00
May 12Shandong Wit Dyne HealthLtd's (SZSE:000915) Earnings Offer More Than Meets The Eye
Apr 24Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,043 | 739 | N/A | 1,419 | 2 |
12/31/2025 | 2,707 | 653 | N/A | 1,265 | 2 |
12/31/2024 | 2,399 | 572 | N/A | 1,134 | 2 |
9/30/2024 | 2,143 | 490 | 733 | 777 | N/A |
6/30/2024 | 2,485 | 595 | 950 | 1,000 | N/A |
3/31/2024 | 2,495 | 590 | 1,019 | 1,069 | N/A |
12/31/2023 | 2,484 | 585 | 1,124 | 1,175 | N/A |
9/30/2023 | 2,241 | 525 | 1,158 | 1,209 | N/A |
6/30/2023 | 2,269 | 544 | 1,108 | 1,184 | N/A |
3/31/2023 | 2,297 | 535 | 1,169 | 1,256 | N/A |
12/31/2022 | 2,341 | 527 | 1,107 | 1,196 | N/A |
9/30/2022 | 2,273 | 524 | 996 | 1,093 | N/A |
6/30/2022 | 2,241 | 456 | 908 | 1,023 | N/A |
3/31/2022 | 2,143 | 427 | 785 | 895 | N/A |
1/1/2022 | 2,027 | 380 | 636 | 756 | N/A |
9/30/2021 | 2,027 | 382 | 693 | 799 | N/A |
6/30/2021 | 2,000 | 385 | 676 | 753 | N/A |
3/31/2021 | 1,986 | 350 | 692 | 777 | N/A |
12/31/2020 | 1,821 | 291 | 634 | 736 | N/A |
9/30/2020 | 1,852 | 277 | 564 | 692 | N/A |
6/30/2020 | 1,821 | 250 | 501 | 643 | N/A |
3/31/2020 | 1,804 | 230 | 257 | 415 | N/A |
12/31/2019 | 1,800 | 204 | 71 | 244 | N/A |
9/30/2019 | 1,562 | 141 | 39 | 223 | N/A |
6/30/2019 | 1,541 | 137 | 17 | 200 | N/A |
3/31/2019 | 1,390 | 80 | 214 | 371 | N/A |
1/1/2019 | 1,526 | 130 | 407 | 539 | N/A |
9/30/2018 | 1,699 | 170 | 376 | 571 | N/A |
6/30/2018 | 1,698 | 178 | N/A | 596 | N/A |
3/31/2018 | 1,775 | 231 | N/A | 509 | N/A |
12/31/2017 | 1,767 | 243 | N/A | 426 | N/A |
9/30/2017 | 1,794 | 255 | N/A | 410 | N/A |
6/30/2017 | 1,694 | 239 | N/A | 422 | N/A |
3/31/2017 | 1,662 | 238 | N/A | 450 | N/A |
12/31/2016 | 1,545 | 198 | N/A | 501 | N/A |
9/30/2016 | 1,529 | 229 | N/A | 474 | N/A |
6/30/2016 | 1,415 | 195 | N/A | 345 | N/A |
3/31/2016 | 1,312 | 156 | N/A | 341 | N/A |
12/31/2015 | 1,233 | 152 | N/A | 290 | N/A |
9/30/2015 | 1,246 | 162 | N/A | 227 | N/A |
6/30/2015 | 1,310 | 206 | N/A | 287 | N/A |
3/31/2015 | 1,317 | 211 | N/A | 236 | N/A |
12/31/2014 | 1,374 | 217 | N/A | 272 | N/A |
9/30/2014 | 1,266 | 178 | N/A | 255 | N/A |
6/30/2014 | 1,198 | 149 | N/A | 230 | N/A |
3/31/2014 | 1,173 | 165 | N/A | 222 | N/A |
12/31/2013 | 1,095 | 153 | N/A | 216 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 000915's forecast earnings growth (16.5% per year) is above the savings rate (2.9%).
Earnings vs Market: 000915's earnings (16.5% per year) are forecast to grow slower than the CN market (25.8% per year).
High Growth Earnings: 000915's earnings are forecast to grow, but not significantly.
Revenue vs Market: 000915's revenue (14.5% per year) is forecast to grow faster than the CN market (14% per year).
High Growth Revenue: 000915's revenue (14.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 000915's Return on Equity is forecast to be high in 3 years time (20.7%)